Kazakhstan has witnessed a decline in measles cases over the past two months, marking a 38% decrease in incidence, the Ministry of Healthcare of Kazakhstan reported. The successful supplementary immunization campaign has seen 92% of eligible individuals receiving vaccination, contributing to this positive trend.
Despite this progress, health authorities urge continued vigilance as measles cases still register within the country. Parents are advised to verify their children's vaccination status and ensure they are adequately protected against this highly contagious disease. For those lacking vaccination, authorities recommend promptly seeking vaccination services at their nearest healthcare facility.
Measles presents symptoms often mistaken for common respiratory infections, including elevated body temperature, coughing, and the emergence of a rash around 4-5 days into the illness. However, the severity of measles lies in its potential complications, including encephalitis, pneumonia, and otitis, underscoring the importance of preventative measures.
Emphasizing the critical role of vaccination, health authorities stress that timely immunization is the most effective strategy for preventing measles outbreaks. Vaccination is recommended for children aged between 1 year and 6 years, offering robust protection against severe illness and its associated consequences.
Kazakhstan relies on World Health Organization (WHO)-certified vaccines in its fight against measles. No adverse events linked to vaccination have been reported within the Republic of Kazakhstan. Minor expected reactions, such as transient fever and local redness or swelling at the injection site, are occasionally noted, reassuring the public of the safety and efficacy of the immunization program.
Measles, caused by the highly contagious measles virus (MeV), manifests with symptoms including fever, cough, runny nose, and a characteristic rash. While most individuals recover without complications, measles can lead to serious health issues such as pneumonia, encephalitis, and permanent hearing loss, particularly in vulnerable populations.
Prevention is primarily achieved through vaccination, with the measles vaccine administered in two doses as part of the measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) series. Despite eradication efforts led by organizations like the World Health Organization (WHO), challenges such as vaccine hesitancy and inadequate healthcare infrastructure persist, contributing to ongoing outbreaks in regions with low vaccination coverage. Supportive care, rather than specific antiviral treatment, is recommended for managing measles cases.
Follow Daryo's official Instagram and Twitter pages to keep current on world news.
Comments (0)